Cephalalgic alopecia areata: A syndrome of neuralgiform head pain and hair loss responsive to botulinum A toxin injection

Cephalalgia

Volumn 26, Issue 6, 2006, Pages 747-751

  Cutrer, F M ^a   Pittelkow, M R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; BUSPIRONE; CODEINE; DEXTROPROPOXYPHENE; GABAPENTIN; HYDROCODONE; INDOMETACIN; MIDODRINE; NORTRIPTYLINE; OPIATE; PROPRANOLOL; TIZANIDINE; TRIAMCINOLONE ACETONIDE;

ADULT; ALOPECIA AREATA; ARTICLE; BACKACHE; BRAIN ANGIOGRAPHY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE SEVERITY; DRUG INDICATION; DRUG MEGADOSE; DRUG TOLERABILITY; FATIGUE; FEMALE; HAIR LOSS; HEADACHE; HUMAN; LABORATORY TEST; MUSCLE SPASM; MYALGIA; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; REMISSION; SCALP; SKIN BIOPSY; TREATMENT OUTCOME;

ADULT; ALOPECIA AREATA; BOTULINUM TOXIN TYPE A; FEMALE; HEADACHE; HUMANS; INJECTIONS, INTRAMUSCULAR; RECURRENCE; SYNDROME; TREATMENT OUTCOME;

EID: 33745194775     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2006.01098.x     Document Type: Article

References (15)

1. MacDonald B. A contribution to the study of cephalgia. J Nervous Mental Dis 1894 19 : 523 5.
2. Sehgal VN, Jain S. Alopecia areata: clinical perspective and an insight into pathogenesis. J Dermatol 2003 30 : 271 89.
3. Messenger AG, Slater DN, Bleechen SS. Alopecia areata: alterations in the low growth cycle and correlation with the follicular pathology. Br J Dermatol 1986 114 : 333 47.
4. Winkelmann RK. Cutaneous sensory nerves. Sem Dermatol 1988 7 : 236 68.
5. Cotsarelis F, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990 61 : 1329 37.
6. Bevin S, Szolscanyi J. Sensory neuron-specific actions of capsaicin: mechanism and applications. TIPS 1990 11 : 330 3.
7. Paus R, Heinzelmann T, Schultz K-D, Furkert J, Fechner K, Czarnetzki BM. Hair growth induction by substance P. Lab Invest 1994 71 : 134 40.
8. Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992 48 : 187 203.
9. Ruocco I, Cuello AC, Shigemoto R, Ribeiro-da-Silva A. Light and electron microscopic study of the distribution of substance P-immunoreactive fibers and neurokinin-1 receptors in the skin of the rat lower lip. J Comp Neurol 2001 432 : 466 80.
10. Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989 143 : 45 9.
11. Wang F, Millet I, Bottomly K, Vignery A. Calcitonin gene-related peptide inhibits interleukin 2 production by murine T lymphocytes. J Biol Chem 1992 267 : 21052 7.
12. 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn-Schmiedebergs Arch Pharmacol 1974 281 : 47 57.
13. Pastor AM, Moreno-Lopez PP, De la Cruz RR, Delgado-Gracia JM. Effects of botulinum neurotoxin type A on abducens motoneurons in the cat: ultrastructural and synaptic alterations. Neuronscience 1997 81 : 457 78.
14. Papadonikolakis AS, Vekris MD, Kostas JP, Korompilias AV, Soucaco PN. Transient erectile dysfunction associated with intramuscular injection of botulinum toxin type A. J South Orthop Assoc 2002 11 : 116 8.
15. Moreno-Lopez B, Pastor AM, Delacruz RR, Delgado-Garcia JM. Dose-dependant, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat. Neurology 1997 48 : 456 64.